11-101-3983
Atorvastatin Calcium Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Manufacturer: MilliporeSigma Supelco
CAS Number: 344423-98-9
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 11-101-3983-Each-of-1 | In Stock | ₹ 12,282.00 |
11-101-3983 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 12,282.00
GST (18%): ₹ 2,210.76
Total Price: ₹ 14,492.76
CAS
344423-98-9
Type
Certified Reference Material
Linear Formula
C66H68 CaF2N4O10 · 3H2 O
Formula Weight
1209.39
Physical Form
Neat
Quantity
1 g
Purity Grade Notes
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Synonym
Atorvastatin hemicalcium salt sesquihydrate
Grade
Certified Reference Material
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
eMolecules AstaTech / CALCIUM (3R5R)-7-(2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4-(PHENYLCARBAMOYL)-1H-PYRROL-1-YL)-35-DIHYDROXYHEPTANOATE TRIHYDRATE / 1g / 718058104 / D83112 / 95.000 / 344423-98-9 / MFCD09752074 / 1209.408 / C66H74CaF2N4O13 | -- | ₹ 4,882.54 | ||
Sigma Aldrich Fine Chemicals Biosciences Atorvastatin Calcium | 344423-98-9 | 100mg | -- | ₹ 47,632.80 | ||
Atorvastatin Calcium | -- | ₹ 10,911.60 | ||
Atorvastatin Calcium | -- | ₹ 40,756.13 | ||
Atorvastatin calcium | -- | ₹ 17,817.95 | ||
Atorvastatin impurity | -- | ₹ 15,533.88 | ||
Calcium (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate trihydrate | -- | ₹ 534.00 - ₹ 17,355.00 | ||
344423-98-9 | Calcium (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate trihydrate | -- | ₹ 3,738.00 - ₹ 7,120.00 |
Related Products
Description
- Atorvastatin Calcium is a synthetic cholesterol lowering agent, which acts as an inhibitor of 3-hydroxy-3-methyl glutaryl coenzyme A reductase
- It is widely used in combination with amlodipine besylate as a medication in the treatment of vasospastic angina, hypertension, chronic stable angina and primary dysbetalipoproteinemia.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
- Featured Industries: Pharmaceutical (small molecule)